These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32020232)

  • 1. High PD‑L1 expression drives glycolysis via an Akt/mTOR/HIF‑1α axis in acute myeloid leukemia.
    Ma P; Xing M; Han L; Gan S; Ma J; Wu F; Huang Y; Chen Y; Tian W; An C; Sun H; Sun L
    Oncol Rep; 2020 Mar; 43(3):999-1009. PubMed ID: 32020232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
    Zhang Y; Liu Y; Xu X
    J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival.
    Feng Y; Wu L
    Biochem Biophys Res Commun; 2017 Feb; 483(2):897-903. PubMed ID: 28082200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
    Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a.
    Huang X; Xie X; Wang H; Xiao X; Yang L; Tian Z; Guo X; Zhang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 Sep; 36(1):129. PubMed ID: 28915924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
    Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
    Cai X; Ding H; Liu Y; Pan G; Li Q; Yang Z; Liu W
    Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):119-127. PubMed ID: 28069585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.
    Ryu MJ; Han J; Kim SJ; Lee MJ; Ju X; Lee YL; Son JH; Cui J; Jang Y; Chung W; Song IC; Kweon GR; Heo JY
    Oncol Rep; 2019 Nov; 42(5):2149-2158. PubMed ID: 31545464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MACC1 regulates PDL1 expression and tumor immunity through the c-Met/AKT/mTOR pathway in gastric cancer cells.
    Tong G; Cheng B; Li J; Wu X; Nong Q; He L; Li X; Li L; Wang S
    Cancer Med; 2019 Nov; 8(16):7044-7054. PubMed ID: 31557409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP14 promotes the growth and glycolysis of acute myeloid leukemia cells by regulating HIF-1α expression.
    Zhu Y; Liu Z; Wan Y; Zou L; Liu L; Ding S; Lu C; Qiu F
    Clin Immunol; 2022 Sep; 242():109094. PubMed ID: 35944879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose induced-AKT/mTOR activation accelerates glycolysis and promotes cell survival in acute myeloid leukemia.
    Chen S; Tao Y; Wang Q; Ren J; Jing Y; Huang J; Zhang L; Li R
    Leuk Res; 2023 May; 128():107059. PubMed ID: 36989577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAF7 inhibits glycolysis to potentiate growth inhibition and apoptosis of myeloid leukemia cells via regulating the KLF2-PFKFB3 axis.
    Zou L; Fang Y; He W
    Mol Cell Probes; 2023 Jun; 69():101911. PubMed ID: 37003349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1/PD-L1 Interaction Regulates BCL2, KI67, BAX, and CASP3, Altering Proliferation, Survival, and Apoptosis in Acute Myeloid Leukemia.
    Soltani M; Vosoughi M; Ganjalikhani-Hakemi M; Shapoorian H; Beshkar P; Eskandari N; Ghezelbash B
    Iran J Allergy Asthma Immunol; 2023 Oct; 22(5):495-503. PubMed ID: 38085150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1α.
    Zhao W; Chang C; Cui Y; Zhao X; Yang J; Shen L; Zhou J; Hou Z; Zhang Z; Ye C; Hasenmayer D; Perkins R; Huang X; Yao X; Yu L; Huang R; Zhang D; Guo H; Yan J
    J Biol Chem; 2014 Apr; 289(16):11219-11229. PubMed ID: 24584933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.
    Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W
    J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt.
    Meng H; Jin Y; Liu H; You L; Yang C; Yang X; Qian W
    J Hematol Oncol; 2013 Feb; 6():18. PubMed ID: 23415012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells.
    Mao L; Chen Q; Gong K; Xu X; Xie Y; Zhang W; Cao H; Hu T; Hong X; Zhan YY
    Oncol Rep; 2018 May; 39(5):2436-2442. PubMed ID: 29565467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AGR2-induced glucose metabolism facilitated the progression of endometrial carcinoma via enhancing the MUC1/HIF-1α pathway.
    Gong W; Ekmu B; Wang X; Lu Y; Wan L
    Hum Cell; 2020 Jul; 33(3):790-800. PubMed ID: 32304027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2‑TAM subsets altered by lactic acid promote T‑cell apoptosis through the PD‑L1/PD‑1 pathway.
    Shan T; Chen S; Chen X; Wu T; Yang Y; Li S; Ma J; Zhao J; Lin W; Li W; Cui X; Kang Y
    Oncol Rep; 2020 Nov; 44(5):1885-1894. PubMed ID: 33000216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.
    Wang Y; Tong H; Wang J; Hu L; Huang Z
    J Mol Histol; 2024 Feb; 55(1):37-50. PubMed ID: 38165568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.